A variety of treatment modalities including insulin, heparin and plasmapheresis have been described in the literature for rapid lowering of serum triglyceride level [1] . However, the efficacy and safety of individual modalities have not been well established and there is no consensus on the management of extreme HTG (serum TG level ≥50mmol/L) (≥4428 mg/dL) in the acute setting. Thus, cases with extremely high TG levels present a management challenge and the objective of this study is to review acute management and clinical course of patients with extreme hypertriglyceridemia.
METHODS
We retrospectively reviewed cases of extreme HTG (serum TG level ≥50mmol/L) (≥4428 mg/dL) presented to our institution between January 2010 and December 2013. Cases were identified from a list of inpatients for which Endocrinology consult was sought. A detailed medical records review was conducted to identify baseline epidemiological and clinical characteristics of these patients, type and effectiveness of treatment modalities used in M A N U S C R I P T
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acute management of extreme HTG. Ethics approval was obtained from the Institutional Human Research Ethics Committee. Contiguous quantitative data were expressed as mean ± SD and were compared using two-tailed Student's t-test. Correlation was assessed by Pearson correlation coefficient. P<0.05 was considered statistically significant.
RESULTS
A total of ten patients presented with extreme HTG (serum TG level ≥50mmol/L) Table 1 shows detailed trends of serum TG levels in individual patients.
Mean capillary glucose level during first 24 hours on IV insulin infusion was 11.5±2.5mmol/L and mean insulin infusion rate during first 24 hours was 3.3±1.6 units/hour for patients with diabetes. There was a significant positive correlation between the mean daily glucose levels and serum TG levels in all patients (r = 0.614, P<0.001). The patients with M A N U S C R I P T
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pancreatitis in our series had uncomplicated clinical courses except one patient (patient 5) developing a pancreatic pseudocyst. Six patients returned for follow-up post discharge and mean nadir serum TG level on follow-up post-discharge was 3.3±2.2mmol/L.
DISCUSSION
Options for immediate management of extreme HTG include insulin (IV/SC), heparin (IV/SC) and/or plasmapheresis [1] . In this study, we found that extreme HTG can be at presentation but we found a similar degree of TG lowering by IV insulin infusion alone.
Moreover, we also found that combination of IV insulin and fasting appears more effective, lowering the TG level by about 87% in 24 hours and achieving the safe TG level <11.3mmol/L in a shorter time frame.
Insulin lowers serum triglyceride level by increasing synthesis and action of peripheral lipoprotein lipase, thereby improving clearance of TG from the circulation [9] . Fasting improves triglyceridemia by reducing the chylomicron formation from the intestine [10] . It has been shown that moderate doses (30-50g) of dietary fat dose-dependently increase postprandial triglyceridemia [11, 12] and the TG response following a fat-containing meal remains elevated for 7-8 hours after the meal even in normolipidemic subjects [13] . Most meals contain 20-70g fat. Clinical studies also support that diets rich in highly digestible carbohydrate can lead to elevation in serum TG as a result of hepatic VLDL and chylomicron M A N U S C R I P T
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remnants accumulation due to altered lipoprotein secretion and/or clearance [14, 15] .
Obesity, insulin resistance and type 2 diabetes are known to be associated with exaggerated postprandial lipemia [10] and hence exclusion of dietary sources by fasting is expected to cause significant improvement of HTG in these patients.
To our knowledge, the degree of benefit of fasting in the setting of severe hypertriglyceridemia has not been reported objectively. In our study, combination of IV insulin and fasting appears to be twice as efficient in rapid lowering of serum TG level compared to IV insulin alone, indicating that fasting is at least as important as insulin in lowering serum TG level. Unfortunately, the degree of TG lowering achievable by fasting alone cannot be commented from our study since uncontrolled diabetes in almost all our cases necessitated the concomitant use of insulin.
Studies using plasmapheresis reported about 40-70% reduction of TG after one session [16, 17] and 60-80% after several sessions [16] [17] [18] . Thus, the degree of the TG lowering effect achieved by the combination of IV insulin and fasting approach (87% in 24 hours) is higher than that reported to be achievable by plasmapheresis. In addition, the combined approach is non-invasive and economical.
We found that extreme HTG is commonly associated with poorly controlled type 2 diabetes. This is consistent with previous studies [2, 4], in support of the central role of insulin resistance leading to reduced clearance and increased production of TG by the liver [19] . Use of insulin infusion in this context has added benefit for management of hyperglycemia and we found a positive correlation between the mean daily glucose levels and serum TG levels. Use of insulin in management of HTG in the absence of diabetes is limited to single case reports [7] and care needs to be taken to avoid hypoglycemia by concurrent administration of glucose in that setting.
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Although the patients in our study were not completely worked up for genetic causes of HTG, it is likely that patients with extreme HTG have some form of underlying genetic defect in lipoprotein metabolism which manifests clinically on interaction with secondary causes such as diabetes, obesity [4, 20] .
Our study is limited by the retrospective nature and relatively small number of cases.
However, to our knowledge, this represents the largest cohort reported to date of patients with extreme hypertriglyceridemia managed with insulin. Given the paucity of literature and lack of consensus around management of extreme HTG, we hope that this paper will form a basis for conducting larger prospective studies to optimise patient outcomes in the immediate management of extreme hypertriglyceridemia.
CONCLUSIONS
Extreme HTG is commonly associated with poorly controlled type 2 diabetes.
Combination of IV insulin and fasting appears to be a very effective, simple and safe treatment strategy in immediate management of extreme HTG.
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Extreme Hypertriglyceridaemia Managed With Insulin
Highlights:
• 10 cases of extreme hypertriglyceridemia (mean triglyceride 8982±2070mg/dL) managed by insulin.
• Compared effectiveness of combined fasting and intravenous insulin approach with intravenous insulin alone.
• Extreme hypertriglyceridaemia is commonly associated with type 2 diabetes. 
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